🔎 Trials Near Me

Akèy › Melanom › Oregon › Portland

Etid klinik pou Melanom nan Portland, OR

15 etid pou Melanom ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Ap rekriteFaz 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Ap rekriteFaz 3
  • Kaiser Foundation Hospitals, Portland
  • Oregon Health and Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06246916

Pan-tumor MRD Study

Ap rekriteEtid obsèvasyon
  • Oregon Health & Science University (OHSU), Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06605404

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Ap rekriteFaz 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04511013

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Legacy Emanuel Children's Hospital, Portland
  • Oregon Health and Science University, Portland
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Providence Cancer Center Oncology and Hematology Care- Eastside, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04895709

A Study of MGC026 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Providence Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Ap rekriteFaz 4
  • OHSU Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT07405086

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 2
  • USA15-0, Portland
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06953089

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Kaiser Permanente Northwest, Portland
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Portland
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Observational Study of Iris Tumors

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Oregon Health & Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT03809585

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Ap rekriteFaz 1/2
  • Oregon Health & Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2025 · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Ap rekrite
  • Kaiser Permanente Northwest - Oncology Clinic, Portland
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883

Etid Melanom nan lòt vil

Lòt etid nan Portland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.